©The Author(s) 2025.
World J Gastroenterol. Oct 21, 2025; 31(39): 111261
Published online Oct 21, 2025. doi: 10.3748/wjg.v31.i39.111261
Published online Oct 21, 2025. doi: 10.3748/wjg.v31.i39.111261
Figure 1 Study flow diagram.
Of 123 intensive care unit hospitalizations screened, 16 were excluded due to early mortality, non-liver related intensive care unit admission, prior transplantation, advanced hepatocellular carcinoma, or missing swabs at admission. The final cohort included 107 patients, categorized as acute decompensation (n = 20) or acute-on-chronic liver failure (n = 87). AD: Acute decompensation; ACLF: Acute-on-chronic liver failure; ICU: Intensive care unit; HCC: Hepatocellular carcinoma; SOT: Solid organ transplant.
- Citation: Kosuta I, Babel J, Domislovic V, Susak F, Peretin L, Varda Brkic D, Marekovic I, Radonic R, Mrzljak A. Clinical impact of multidrug-resistant organisms in liver cirrhosis: A retrospective cohort study in the intensive care setting. World J Gastroenterol 2025; 31(39): 111261
- URL: https://www.wjgnet.com/1007-9327/full/v31/i39/111261.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i39.111261